Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma

Giuseppe Grandaliano, Massimo Papale, Grazia Vocino, Giuseppe Lucarelli, Monica Rutigliano, Margherita Gigante, Maria Teresa Rocchetti, Francesco Pesce, Francesca Sanguedolce, Pantaleo Bufo, Michele Battaglia, Giovanni Stallone, Giuseppe Carrieri, Loreto Gesualdo, Elena Ranieri

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

28 Citazioni (Scopus)

Abstract

Clear cell Renal Cell Carcinoma (ccRCC) causes over 13,000 deaths each year, and about 20,000 new cases/year in Europe. In most cases, the causes are unknown and, most importantly, there are no reliable biomarkers for the diagnosis and prognosis of this disease. The search for sensitive biomarkers for early diagnosis and prognosis of clear cell Renal Cell Carcinoma (ccRCC) is currently a fast growing field. We carried out proteomics analysis of 93 urinary samples of healthy subjects (HS) and patients affected by ccRCC, prostate cancer (PCa) and chronic kidney disease (CKD), that was able to successfully distinguish each group. The most significant candidate biomarker was identified by mass spectrometry as Raf Kinase Inhibitor Protein (RKIP), a key regulator of cell signaling, already described in several cancer types as a metastasis suppressor. By combining ELISA, immunoblotting and tissue microarray, we demonstrated that, in ccRCC, urinary excretion of RKIP and its phosphorylated form (p-RKIP) reflected the tissue expression of these putative biomarkers. Baseline urinary RKIP, evaluated in an independent cohort of 56 ccRCC patients and 28 HS, successfully distinguished both groups and, most importantly, a cut-offvalue of 10 ng/mg/g Pr/uCr enabled a highly accurate prediction of Cancer-specific survival and Progression-free survival. Furthermore, p-RKIP was totally undetectable in both tissue and urine samples of ccRCC, showing a great potential for diagnostics purposes. Our data indicate that urinary RKIP encompasses both the unphosphorylated and the phosphorylated form and that their combined evaluation can help in the diagnosis and prognosis of ccRCC.
Lingua originaleEnglish
pagine (da-a)40412-40424
Numero di pagine13
RivistaOncotarget
Volume8
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Adult
  • Biomarkers
  • Biomarkers, Tumor
  • Carcinoma, Renal Cell
  • Clear cell renal cell carcinoma
  • Disease-Free Survival
  • Enzyme-Linked Immunosorbent Assay
  • Europe
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Neoplasms
  • Phosphatidylethanolamine Binding Protein
  • Phospho-RKIP
  • Phosphorylation
  • RKIP
  • Renal Insufficiency, Chronic
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Tissue Array Analysis
  • Urine

Fingerprint Entra nei temi di ricerca di 'Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma'. Insieme formano una fingerprint unica.

Cita questo